Safety and Tolerability of Ecopipam in Tourette Syndrome with Psychiatric Comorbidities

Dr. Donald Gilbert shares promising results for a drug that interacts with the D1 pathway to treat the motor symptoms of children with Tourette syndrome and psychiatric conditions, like ADHD or OCD. This highlighted research was presented during the 2024 International Congress of Parkinson’s Disease and Movement Disorders (mdscongress.org). Authors: D. Gilbert, S. Atkinson, G. Karkanias, R. Munschauer, S. Wanaski, T. Cunniff (Cincinnati, USA). Funded by Emalex Biosciences. Read the full abstract at mdsabstracts.org.